Resumen de A report from the 16th Annual IGPA Conference (December 9-11, 2013 – Brussels, Belgium).
The 16th annual International Generic Pharmaceutical Alliance (IGPA) conference brought together approximately 200 attendees representing 35 nations. The IGPA consists of generic industry associations from the United States (GPhA), Canada (CGPA), Europe (EGA), Jordan (JAPM), South Africa (NAPM), and Japan (JGA), in addition to observer member organizations from Brazil (PróGenéricos), Mexico (AMEGI) and Taiwan (TGPA). Conference attendees listened to industry experts and participating organization representatives present some of the key issues affecting the generic industry. Nick Haggar (President, EGA) welcomed attendees by highlighting the impact that IGPA and its member alliance associations have on healthcare around the world. The 2-day conference reviewed the trends in 11 different markets, the ongoing trade negotiations between numerous countries and the role generic associations in their respective countries can have in increasing patient access to affordable high-quality medicines.
